Breaking News
Get 40% Off 0
🔎 See NVDA full ProTips for an instant risks or rewards Claim 40% OFF

Pharmaceutical and retail giants to report financials amidst mixed market conditions

Published Oct 28, 2023 03:22
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
© Reuters.
 
NOVOb
-1.96%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
GSK
-1.18%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
HLN
-0.54%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
NXT
-0.09%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
BASFY
-0.40%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
BP
-0.20%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 

Pharmaceutical companies Novo Nordisk (NYSE:NVO) A/S, GSK Plc, Haleon Plc, and BASF SE (OTC:BASFY) are scheduled to announce their financial results next week amidst a range of market conditions. Novo Nordisk's diabetes and weight-loss drugs Ozempic and Wegovy have experienced a surge in demand, propelling it to become Europe's most valuable listed company. However, production constraints could potentially impede sales growth.

GSK has seen its stock price increase due to the prospects for its respiratory virus vaccine Arexvy, which may have generated $300 million in revenue. Despite this, the company's stock has declined following Haleon's demerger in July 2022. GSK is also faced with ongoing litigation risks pertaining to Zantac lawsuits. The launch of Arexvy is expected to boost sales, despite a likely year-on-year drop in group revenue.

Haleon Plc is anticipated to deliver organic growth within its guided medium-term range of 4% to 6% in Q3. This forecast comes after GSK sold a $1.1 billion stake in the company, reducing its holding to 7.4%.

Clothing retailers Next Plc and Hugo Boss AG are set to report their financials against a backdrop of declining consumer sentiment. Hugo Boss's sales growth is projected to halve from the last quarter. However, the company hopes that its refined casualwear will attract luxury customers looking to trade down.

Next Plc's forecast will be closely examined against shaky consumer sentiment. Despite this, the company's robust online presence positions it well for potential market-share gains.

Chemical companies Solvay (EBR:SOLB) SA and BASF are dealing with weak demand across divisions. BASF is likely to report contracted margins in Q3 due to a sluggish economy and has implemented cost-cutting measures to alleviate margin pressure. Solvay is expected to announce depressed volumes and falling prices. Despite these challenges, Solvay is progressing with plans to split into two publicly listed companies.

BP (NYSE:BP) Plc will likely report strong sequential growth in Q3 adjusted earnings due to stable upstream production volumes and new project ramp-ups. The company may also announce another $1.5 billion buyback for the final quarter. Simultaneously, BP is in the process of finding a new chief executive following Bernard Looney's unexpected departure.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Pharmaceutical and retail giants to report financials amidst mixed market conditions
 

Related Articles

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email